TELA Bio (TELA) Stock Price Target 2026

The average analyst price target for TELA Bio is $4.50, 435.7% above the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $1 to $12. The latest change came on Sep 25, 2026, when Craig-Hallum initiated coverage of TELA Bio with a Buy rating and a $2 price target.

The Average Analyst Price Target for TELA Bio is $4.50.

Price Target Range — 9 Quarters

Analyst Consensus — 7 Analysts

3S.Buy

3Buy

1Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$4.50Upside to Avg. PT+435.7%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for TELA Bio Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 25, 2026	Craig-Hallum	Chase Knickerbocker	Initiate	Buy	$2
Mar 27, 2026	Citizens	David Turkaly	PT Cut	Market Outperform	$5→$3
Mar 25, 2026	Piper Sandler	Matt O'Brien	PT Cut	Neutral	$1→$1
Mar 25, 2026	Lake Street	Frank Takkinen	PT Cut	Buy	$3→$2
Mar 25, 2026	Canaccord Genuity	Caitlin Roberts	PT Cut	Buy	$4→$2
Dec 1, 2025	Lake Street	Frank Takkinen	PT Cut	Buy	$6→$3
Nov 18, 2025	Canaccord Genuity	Caitlin Roberts	PT Cut	Buy	$7→$4
Nov 14, 2025	Piper Sandler	Matt O'Brien	PT Cut	Neutral	$2→$1
Nov 14, 2025	Citizens	David Turkaly	PT Cut	Market Outperform	$7→$5
Mar 21, 2025	Canaccord Genuity	Caitlin Cronin	PT Cut	Buy	$12→$7
Mar 21, 2025	Citizens Capital Markets	David Turkaly	PT Cut	Market Outperform	$12→$7
Mar 21, 2025	Piper Sandler	Matt O'Brien	Downgrade	Overweight→Neutral	$5→$2
Nov 8, 2024	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$8→$5
Oct 4, 2024	Canaccord Genuity	Caitlin Cronin	Maintained	Buy	$12
Aug 13, 2024	JMP Securities	David Turkaly	PT Cut	Market Outperform	$15→$12
Aug 13, 2024	Lake Street	Frank Takkinen	PT Cut	Buy	$14→$8
Aug 13, 2024	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$10→$8
Aug 13, 2024	Canaccord Genuity	Caitlin Cronin	PT Cut	Buy	$14→$12
Jul 25, 2024	Canaccord Genuity	Caitlin Cronin	Maintained	Buy	$14
May 10, 2024	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$12→$10